Comprehensive Market Analysis on Antibody Discovery Market projected to reach USD USD 13.7 Billion by 2030 | CAGR of 9.0% | Forecast period 2023-2030, published by MarketDigits

Antibody Discovery Market Scope:
Market size value in 2023 - USD 6.9 Billion
Market size value in 2030 - USD 13.7 Billion
CAGR (2023-2030) - 9.0%
Forecast Period - 2023-2030
Segments Covered - Source, Antibody Type, Method, End-user & Region
Geographies Covered - North America, Europe, Asia Pacific, and Row
Sample of Companies Covered - Charles River Laboratories, Creative Biolabs, Danaher Corporation, Eurofins Scientific, Evotec, Fairjourney Biologics S.A.

Download Sample Pages-https://www.marketdigits.com/request/sample/3712

Browse in-depth TOC on "Antibody Discovery Market"
178-Tables
95-Figures
332-Pages

North America dominates the market for Antibody Discovery.
In 2022, the North American Antibody Discovery Market is anticipated to dominate in the forecast period, propelled by an increase in cancer prevalence, a robust presence of the antibody discovery industry, and technological advancements in the R&D sector. For instance, in 2020, the American Cancer Society reported approximately 1.8 million new cancer cases and 606,520 cancer-related deaths in the U.S., underscoring the demand for therapeutic antibodies and stimulating market growth. The upsurge in funding facilitates the development of novel technologies, collaborative efforts spanning countries and organizations, and the exploration of existing antibody treatments, contributing to a deeper understanding of the immune system and the effective development of targeted antibodies. Moreover, augmented funding enables large-scale clinical trials essential for evaluating antibody efficacy, thereby enhancing the overall growth trajectory of the market.
On the other hand, the Asia-Pacific antibody discovery market is poised for expansion in the forecast period due to an increase in the incidence of cardiovascular diseases and other chronic health conditions. As reported by the Journal of Biomedical and Environmental Science in 2021, approximately 330 million individuals in China experienced cardiovascular diseases. The significance of antibody discovery becomes evident in the creation of innovative therapeutics for addressing cardiovascular ailments. Consequently, the rising prevalence of heart diseases amplifies the demand for antibody discovery, playing a pivotal role in propelling market growth.

Ask for Discount- https://www.marketdigits.com/request/discount/3712

Top Key Players Covered in the Report-
Biocytogen, Charles River Laboratories, Creative Biolabs, Danaher Corporation, Eurofins Scientific, Evotec, Fairjourney Biologics S.A, Genscript Technology Corporation, Sartorius AG, Twist Bioscience and Others.

For More Information - Inquire Now!
https://www.marketdigits.com/request/enquiry-before-buying/3712

Recent Developments:
In October 2023, AbbVie initiated Phase 1 clinical trial of Rovalpituzumab tesirine (Rova-T), an antibody-drug conjugate (ADC) targeting Nectin-4 for the treatment of solid tumors

https://industrytoday.co.uk/market-research-industry-today/emerging-trends-and-innovations-for-the-antibody-discovery-market-projected-to-reach-usd-137-billion-by-2030

MarketDigits
Email: sales@marketdigits.com

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

This release was published on openPR.